Cost of care according to disease-modifying therapy in Mexicans with relapsing-remitting multiple sclerosis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-12

AUTHORS

Miguel A. Macías-Islas, Isaac F. Soria-Cedillo, Merced Velazquez-Quintana, Victor M. Rivera, Verónica I. Baca-Muro, Edith A. Lemus-Carmona, Erwin Chiquete

ABSTRACT

Limited data exist on the costs of care of patients with multiple sclerosis (MS) in low- to middle-income nations. The purpose of this study was to describe the economic burden associated with care of Mexican patients with relapsing-remitting MS in a representative sample of the largest institution of the Mexican public healthcare system. We analysed individual data of 492 patients (67% women) with relapsing-remitting MS registered from January 2009 to February 2011 at the Mexican Social Security Institute. Direct costs were measured about the use of diagnostic tests, disease-modifying therapies (DMTs), symptoms control, medical consultations, relapses, intensive care and rehabilitation. Four groups were defined according to DMT alternatives: (1) interferon beta (IFNβ)-1a, 6 million units (MU); (2) IFNβ-1a, 12MU; (3) IFNβ-1b, 8MU; and (4) glatiramer acetate. All patients received DMTs for at least 1 year. The most frequently used DMT was glatiramer acetate (45.5%), followed by IFNβ-1a 12MU (22.6%), IFNβ-1b 8MU (20.7%), and IFNβ-1a 6MU (11.2%). The mean cost of a specialised medical consultation was €74.90 (US $107.00). A single relapse had a mean total cost of €2,505.97 (US $3,579.96). No differences were found in annualised relapse rates and costs of relapses according to DMT. However, a significant difference was observed in total annual costs according to treatment groups (glatiramer acetate being the most expensive), mainly due to differences in unitary costs of alternatives. From the public institutional perspective, when equipotent DMTs are used in patients with comparable characteristics, the costs of DMTs largely determine the total expenses associated with care of patients with relapsing-remitting MS in a middle-income country. More... »

PAGES

415-420

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13760-013-0200-z

DOI

http://dx.doi.org/10.1007/s13760-013-0200-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1042655609

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23670405


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glatiramer Acetate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Health Care Costs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunosuppressive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interferon-beta", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mexico", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multiple Sclerosis, Relapsing-Remitting", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peptides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Guadalajara", 
          "id": "https://www.grid.ac/institutes/grid.412890.6", 
          "name": [
            "Jefe del Departamento de Neurolog\u00eda, UMAE, Centro M\u00e9dico Nacional de Occidente, IMSS, Belisario Dom\u00ednguez #1000, Col. Independencia Oriente, C.P. 44340, Guadalajara, Jal, Mexico", 
            "Department of Neurosciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jal, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mac\u00edas-Islas", 
        "givenName": "Miguel A.", 
        "id": "sg:person.01211015253.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211015253.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novartis (Mexico)", 
          "id": "https://www.grid.ac/institutes/grid.492888.7", 
          "name": [
            "Department of Health Economics, Novartis Mexico, Mexico City, DF, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Soria-Cedillo", 
        "givenName": "Isaac F.", 
        "id": "sg:person.07643445635.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07643445635.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department Health Research, Hospital Regional #1, IMSS, Chihuahua, Chi, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Velazquez-Quintana", 
        "givenName": "Merced", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Baylor College of Medicine", 
          "id": "https://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "The Maxine Mesinger MS Comprehensive Care Centre, Baylor College of Medicine, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rivera", 
        "givenName": "Victor M.", 
        "id": "sg:person.01325735727.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01325735727.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novartis (Mexico)", 
          "id": "https://www.grid.ac/institutes/grid.492888.7", 
          "name": [
            "Department of Health Economics, Novartis Mexico, Mexico City, DF, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baca-Muro", 
        "givenName": "Ver\u00f3nica I.", 
        "id": "sg:person.014753556035.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014753556035.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novartis (Mexico)", 
          "id": "https://www.grid.ac/institutes/grid.492888.7", 
          "name": [
            "Department of Health Economics, Novartis Mexico, Mexico City, DF, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lemus-Carmona", 
        "givenName": "Edith A.", 
        "id": "sg:person.01057174337.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057174337.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n", 
          "id": "https://www.grid.ac/institutes/grid.416850.e", 
          "name": [
            "Department of Neurology and Psychiatry, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n \u201cSalvador Zubir\u00e1n\u201d, Mexico City, DF, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chiquete", 
        "givenName": "Erwin", 
        "id": "sg:person.0744250106.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744250106.40"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.3111/13696998.2012.654868", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007355315"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13760-012-0063-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008706867", 
          "https://doi.org/10.1007/s13760-012-0063-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3988/jcn.2009.5.4.173", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011744146"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3988/jcn.2009.5.4.173", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011744146"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1590/s0004-282x2012000200006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014817327"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0303-8467(02)00036-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018466376"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jval.2011.05.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020022518"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/11592160-000000000-00000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020476089", 
          "https://doi.org/10.2165/11592160-000000000-00000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1472-6963-6-143", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020764603", 
          "https://doi.org/10.1186/1472-6963-6-143"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clinthera.2012.06.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023304029"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1468-1331.2001.00169.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031662403"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458512447262", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033642573"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458512447262", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033642573"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458512447262", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033642573"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11910-012-0291-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036277151", 
          "https://doi.org/10.1007/s11910-012-0291-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000331043", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043846287"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458511429319", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046319945"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458511429319", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046319945"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458511429319", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046319945"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.22366", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052372006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458511405562", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063989005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458511405562", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063989005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1352458511405562", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063989005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1756285611423560", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064076753"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1756285611423560", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064076753"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000218309.01322.5c", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064348155"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000218309.01322.5c", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064348155"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000218309.01322.5c", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064348155"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3182270402", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064356318"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3182270402", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064356318"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3182270402", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064356318"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075301198", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.33588/rn.3611.2002610", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1075301198"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077377441", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078422353", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.33588/rn.5303.2010683", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078422353"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078422404", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078424297", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-12", 
    "datePublishedReg": "2013-12-01", 
    "description": "Limited data exist on the costs of care of patients with multiple sclerosis (MS) in low- to middle-income nations. The purpose of this study was to describe the economic burden associated with care of Mexican patients with relapsing-remitting MS in a representative sample of the largest institution of the Mexican public healthcare system. We analysed individual data of 492 patients (67% women) with relapsing-remitting MS registered from January 2009 to February 2011 at the Mexican Social Security Institute. Direct costs were measured about the use of diagnostic tests, disease-modifying therapies (DMTs), symptoms control, medical consultations, relapses, intensive care and rehabilitation. Four groups were defined according to DMT alternatives: (1) interferon beta (IFN\u03b2)-1a, 6 million units (MU); (2) IFN\u03b2-1a, 12MU; (3) IFN\u03b2-1b, 8MU; and (4) glatiramer acetate. All patients received DMTs for at least 1 year. The most frequently used DMT was glatiramer acetate (45.5%), followed by IFN\u03b2-1a 12MU (22.6%), IFN\u03b2-1b 8MU (20.7%), and IFN\u03b2-1a 6MU (11.2%). The mean cost of a specialised medical consultation was \u20ac74.90 (US $107.00). A single relapse had a mean total cost of \u20ac2,505.97 (US $3,579.96). No differences were found in annualised relapse rates and costs of relapses according to DMT. However, a significant difference was observed in total annual costs according to treatment groups (glatiramer acetate being the most expensive), mainly due to differences in unitary costs of alternatives. From the public institutional perspective, when equipotent DMTs are used in patients with comparable characteristics, the costs of DMTs largely determine the total expenses associated with care of patients with relapsing-remitting MS in a middle-income country.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s13760-013-0200-z", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1312027", 
        "issn": [
          "0300-9009", 
          "2240-2993"
        ], 
        "name": "Acta Neurologica Belgica", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "113"
      }
    ], 
    "name": "Cost of care according to disease-modifying therapy in Mexicans with relapsing-remitting multiple sclerosis", 
    "pagination": "415-420", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "cb2fb3d4556a27ea5b174f801b0f5f9fcd9df2ead111eb2370d3d09517e46006"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23670405"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0247035"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13760-013-0200-z"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1042655609"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13760-013-0200-z", 
      "https://app.dimensions.ai/details/publication/pub.1042655609"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:11", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000523.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs13760-013-0200-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13760-013-0200-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13760-013-0200-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13760-013-0200-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13760-013-0200-z'


 

This table displays all metadata directly associated to this object as RDF triples.

259 TRIPLES      21 PREDICATES      70 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13760-013-0200-z schema:about N16b040c167f648db837d814badfb1d6c
2 N2e3f133889af49f28928b45e45364706
3 N33a3a3f7c98147389ca3ada83069bc99
4 N63d72bffd94b468384f76cef0f335986
5 N703d905605cf480b872a299adf435581
6 N82cb7dc82332430a94f79ed0ce835956
7 N84c47062bbb94ea9acf6af695e5cf471
8 Na9cfb2ab78134b08ae35b75cd46be7fb
9 Naf12b648e4004c3d833542b4c42ed61d
10 Nbc4df45fd0074771a6160836c91d8dd3
11 Nc8f067d17ca742359e76b0aa1a638833
12 Ne3f37047d7fb4bc292d7094e468383f0
13 Nea4ea03e5aa1480098df35412b746f31
14 Nf3063ef52043467783cad9f5824e2ca0
15 Nfeb430ee496f484fafb803e033320a72
16 anzsrc-for:11
17 anzsrc-for:1103
18 schema:author Neeb47ef52b404aa6bf9ac0841ad15fe6
19 schema:citation sg:pub.10.1007/s11910-012-0291-6
20 sg:pub.10.1007/s13760-012-0063-8
21 sg:pub.10.1186/1472-6963-6-143
22 sg:pub.10.2165/11592160-000000000-00000
23 https://app.dimensions.ai/details/publication/pub.1075301198
24 https://app.dimensions.ai/details/publication/pub.1077377441
25 https://app.dimensions.ai/details/publication/pub.1078422353
26 https://app.dimensions.ai/details/publication/pub.1078422404
27 https://app.dimensions.ai/details/publication/pub.1078424297
28 https://doi.org/10.1002/ana.22366
29 https://doi.org/10.1016/j.clinthera.2012.06.012
30 https://doi.org/10.1016/j.jval.2011.05.023
31 https://doi.org/10.1016/s0303-8467(02)00036-7
32 https://doi.org/10.1046/j.1468-1331.2001.00169.x
33 https://doi.org/10.1159/000331043
34 https://doi.org/10.1177/1352458511405562
35 https://doi.org/10.1177/1352458511429319
36 https://doi.org/10.1177/1352458512447262
37 https://doi.org/10.1177/1756285611423560
38 https://doi.org/10.1212/01.wnl.0000218309.01322.5c
39 https://doi.org/10.1212/wnl.0b013e3182270402
40 https://doi.org/10.1590/s0004-282x2012000200006
41 https://doi.org/10.3111/13696998.2012.654868
42 https://doi.org/10.33588/rn.3611.2002610
43 https://doi.org/10.33588/rn.5303.2010683
44 https://doi.org/10.3988/jcn.2009.5.4.173
45 schema:datePublished 2013-12
46 schema:datePublishedReg 2013-12-01
47 schema:description Limited data exist on the costs of care of patients with multiple sclerosis (MS) in low- to middle-income nations. The purpose of this study was to describe the economic burden associated with care of Mexican patients with relapsing-remitting MS in a representative sample of the largest institution of the Mexican public healthcare system. We analysed individual data of 492 patients (67% women) with relapsing-remitting MS registered from January 2009 to February 2011 at the Mexican Social Security Institute. Direct costs were measured about the use of diagnostic tests, disease-modifying therapies (DMTs), symptoms control, medical consultations, relapses, intensive care and rehabilitation. Four groups were defined according to DMT alternatives: (1) interferon beta (IFNβ)-1a, 6 million units (MU); (2) IFNβ-1a, 12MU; (3) IFNβ-1b, 8MU; and (4) glatiramer acetate. All patients received DMTs for at least 1 year. The most frequently used DMT was glatiramer acetate (45.5%), followed by IFNβ-1a 12MU (22.6%), IFNβ-1b 8MU (20.7%), and IFNβ-1a 6MU (11.2%). The mean cost of a specialised medical consultation was €74.90 (US $107.00). A single relapse had a mean total cost of €2,505.97 (US $3,579.96). No differences were found in annualised relapse rates and costs of relapses according to DMT. However, a significant difference was observed in total annual costs according to treatment groups (glatiramer acetate being the most expensive), mainly due to differences in unitary costs of alternatives. From the public institutional perspective, when equipotent DMTs are used in patients with comparable characteristics, the costs of DMTs largely determine the total expenses associated with care of patients with relapsing-remitting MS in a middle-income country.
48 schema:genre research_article
49 schema:inLanguage en
50 schema:isAccessibleForFree false
51 schema:isPartOf N8ed5ed3c419840168fa672e423dd5996
52 Nae0969c76b2c40499f36accca6adee30
53 sg:journal.1312027
54 schema:name Cost of care according to disease-modifying therapy in Mexicans with relapsing-remitting multiple sclerosis
55 schema:pagination 415-420
56 schema:productId N33e43c6769164ca2a882f4b378cde85b
57 N8b19c5095c6146e8b0808c08f84eac8d
58 N9a71703ea3af43fc887c61d3e3fb12c3
59 N9eda4d07b6d7462199027074e8bb03c2
60 Nee5515d6bc4a4322855d0e952541a24f
61 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042655609
62 https://doi.org/10.1007/s13760-013-0200-z
63 schema:sdDatePublished 2019-04-10T19:11
64 schema:sdLicense https://scigraph.springernature.com/explorer/license/
65 schema:sdPublisher N633a4ddf16144d2cba61df217debd937
66 schema:url http://link.springer.com/10.1007%2Fs13760-013-0200-z
67 sgo:license sg:explorer/license/
68 sgo:sdDataset articles
69 rdf:type schema:ScholarlyArticle
70 N16b040c167f648db837d814badfb1d6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Aged
72 rdf:type schema:DefinedTerm
73 N17106a6350d849bfbfb2e8c982627410 rdf:first Ncb530e047a5f45e8941186641a07c169
74 rdf:rest Nf31f6103f4e34f2788c98cff0004c5b6
75 N2e3f133889af49f28928b45e45364706 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Immunosuppressive Agents
77 rdf:type schema:DefinedTerm
78 N32405f8136b345e495a12fbc3f21f2df rdf:first sg:person.01057174337.35
79 rdf:rest Nb50a23bde93e4a3783894327846e9dbc
80 N33a3a3f7c98147389ca3ada83069bc99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Interferon-beta
82 rdf:type schema:DefinedTerm
83 N33e43c6769164ca2a882f4b378cde85b schema:name dimensions_id
84 schema:value pub.1042655609
85 rdf:type schema:PropertyValue
86 N633a4ddf16144d2cba61df217debd937 schema:name Springer Nature - SN SciGraph project
87 rdf:type schema:Organization
88 N63d72bffd94b468384f76cef0f335986 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Female
90 rdf:type schema:DefinedTerm
91 N703d905605cf480b872a299adf435581 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Peptides
93 rdf:type schema:DefinedTerm
94 N82cb7dc82332430a94f79ed0ce835956 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Middle Aged
96 rdf:type schema:DefinedTerm
97 N84c47062bbb94ea9acf6af695e5cf471 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Multiple Sclerosis, Relapsing-Remitting
99 rdf:type schema:DefinedTerm
100 N8b19c5095c6146e8b0808c08f84eac8d schema:name readcube_id
101 schema:value cb2fb3d4556a27ea5b174f801b0f5f9fcd9df2ead111eb2370d3d09517e46006
102 rdf:type schema:PropertyValue
103 N8ed5ed3c419840168fa672e423dd5996 schema:issueNumber 4
104 rdf:type schema:PublicationIssue
105 N9a71703ea3af43fc887c61d3e3fb12c3 schema:name doi
106 schema:value 10.1007/s13760-013-0200-z
107 rdf:type schema:PropertyValue
108 N9eda4d07b6d7462199027074e8bb03c2 schema:name nlm_unique_id
109 schema:value 0247035
110 rdf:type schema:PropertyValue
111 Na9cfb2ab78134b08ae35b75cd46be7fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Adult
113 rdf:type schema:DefinedTerm
114 Nae0969c76b2c40499f36accca6adee30 schema:volumeNumber 113
115 rdf:type schema:PublicationVolume
116 Naf12b648e4004c3d833542b4c42ed61d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Glatiramer Acetate
118 rdf:type schema:DefinedTerm
119 Nb50a23bde93e4a3783894327846e9dbc rdf:first sg:person.0744250106.40
120 rdf:rest rdf:nil
121 Nbc4df45fd0074771a6160836c91d8dd3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Health Care Costs
123 rdf:type schema:DefinedTerm
124 Nc8f067d17ca742359e76b0aa1a638833 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Mexico
126 rdf:type schema:DefinedTerm
127 Ncb530e047a5f45e8941186641a07c169 schema:affiliation Nfb92939dccc145e3a360e009c5718950
128 schema:familyName Velazquez-Quintana
129 schema:givenName Merced
130 rdf:type schema:Person
131 Nd12e3597c9dd434e94c3d0804149f2e1 rdf:first sg:person.07643445635.30
132 rdf:rest N17106a6350d849bfbfb2e8c982627410
133 Nd70f70aeb23340cda2a7a57d34b67e88 rdf:first sg:person.014753556035.52
134 rdf:rest N32405f8136b345e495a12fbc3f21f2df
135 Ne3f37047d7fb4bc292d7094e468383f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Young Adult
137 rdf:type schema:DefinedTerm
138 Nea4ea03e5aa1480098df35412b746f31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Retrospective Studies
140 rdf:type schema:DefinedTerm
141 Nee5515d6bc4a4322855d0e952541a24f schema:name pubmed_id
142 schema:value 23670405
143 rdf:type schema:PropertyValue
144 Neeb47ef52b404aa6bf9ac0841ad15fe6 rdf:first sg:person.01211015253.11
145 rdf:rest Nd12e3597c9dd434e94c3d0804149f2e1
146 Nf3063ef52043467783cad9f5824e2ca0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Humans
148 rdf:type schema:DefinedTerm
149 Nf31f6103f4e34f2788c98cff0004c5b6 rdf:first sg:person.01325735727.46
150 rdf:rest Nd70f70aeb23340cda2a7a57d34b67e88
151 Nfb92939dccc145e3a360e009c5718950 schema:name Department Health Research, Hospital Regional #1, IMSS, Chihuahua, Chi, Mexico
152 rdf:type schema:Organization
153 Nfeb430ee496f484fafb803e033320a72 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Male
155 rdf:type schema:DefinedTerm
156 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
157 schema:name Medical and Health Sciences
158 rdf:type schema:DefinedTerm
159 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
160 schema:name Clinical Sciences
161 rdf:type schema:DefinedTerm
162 sg:journal.1312027 schema:issn 0300-9009
163 2240-2993
164 schema:name Acta Neurologica Belgica
165 rdf:type schema:Periodical
166 sg:person.01057174337.35 schema:affiliation https://www.grid.ac/institutes/grid.492888.7
167 schema:familyName Lemus-Carmona
168 schema:givenName Edith A.
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057174337.35
170 rdf:type schema:Person
171 sg:person.01211015253.11 schema:affiliation https://www.grid.ac/institutes/grid.412890.6
172 schema:familyName Macías-Islas
173 schema:givenName Miguel A.
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211015253.11
175 rdf:type schema:Person
176 sg:person.01325735727.46 schema:affiliation https://www.grid.ac/institutes/grid.39382.33
177 schema:familyName Rivera
178 schema:givenName Victor M.
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01325735727.46
180 rdf:type schema:Person
181 sg:person.014753556035.52 schema:affiliation https://www.grid.ac/institutes/grid.492888.7
182 schema:familyName Baca-Muro
183 schema:givenName Verónica I.
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014753556035.52
185 rdf:type schema:Person
186 sg:person.0744250106.40 schema:affiliation https://www.grid.ac/institutes/grid.416850.e
187 schema:familyName Chiquete
188 schema:givenName Erwin
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744250106.40
190 rdf:type schema:Person
191 sg:person.07643445635.30 schema:affiliation https://www.grid.ac/institutes/grid.492888.7
192 schema:familyName Soria-Cedillo
193 schema:givenName Isaac F.
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07643445635.30
195 rdf:type schema:Person
196 sg:pub.10.1007/s11910-012-0291-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036277151
197 https://doi.org/10.1007/s11910-012-0291-6
198 rdf:type schema:CreativeWork
199 sg:pub.10.1007/s13760-012-0063-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008706867
200 https://doi.org/10.1007/s13760-012-0063-8
201 rdf:type schema:CreativeWork
202 sg:pub.10.1186/1472-6963-6-143 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020764603
203 https://doi.org/10.1186/1472-6963-6-143
204 rdf:type schema:CreativeWork
205 sg:pub.10.2165/11592160-000000000-00000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020476089
206 https://doi.org/10.2165/11592160-000000000-00000
207 rdf:type schema:CreativeWork
208 https://app.dimensions.ai/details/publication/pub.1075301198 schema:CreativeWork
209 https://app.dimensions.ai/details/publication/pub.1077377441 schema:CreativeWork
210 https://app.dimensions.ai/details/publication/pub.1078422353 schema:CreativeWork
211 https://app.dimensions.ai/details/publication/pub.1078422404 schema:CreativeWork
212 https://app.dimensions.ai/details/publication/pub.1078424297 schema:CreativeWork
213 https://doi.org/10.1002/ana.22366 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052372006
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1016/j.clinthera.2012.06.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023304029
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1016/j.jval.2011.05.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020022518
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1016/s0303-8467(02)00036-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018466376
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1046/j.1468-1331.2001.00169.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1031662403
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1159/000331043 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043846287
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1177/1352458511405562 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063989005
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1177/1352458511429319 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046319945
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1177/1352458512447262 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033642573
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1177/1756285611423560 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064076753
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1212/01.wnl.0000218309.01322.5c schema:sameAs https://app.dimensions.ai/details/publication/pub.1064348155
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1212/wnl.0b013e3182270402 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064356318
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1590/s0004-282x2012000200006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014817327
238 rdf:type schema:CreativeWork
239 https://doi.org/10.3111/13696998.2012.654868 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007355315
240 rdf:type schema:CreativeWork
241 https://doi.org/10.33588/rn.3611.2002610 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075301198
242 rdf:type schema:CreativeWork
243 https://doi.org/10.33588/rn.5303.2010683 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078422353
244 rdf:type schema:CreativeWork
245 https://doi.org/10.3988/jcn.2009.5.4.173 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011744146
246 rdf:type schema:CreativeWork
247 https://www.grid.ac/institutes/grid.39382.33 schema:alternateName Baylor College of Medicine
248 schema:name The Maxine Mesinger MS Comprehensive Care Centre, Baylor College of Medicine, Houston, TX, USA
249 rdf:type schema:Organization
250 https://www.grid.ac/institutes/grid.412890.6 schema:alternateName University of Guadalajara
251 schema:name Department of Neurosciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jal, Mexico
252 Jefe del Departamento de Neurología, UMAE, Centro Médico Nacional de Occidente, IMSS, Belisario Domínguez #1000, Col. Independencia Oriente, C.P. 44340, Guadalajara, Jal, Mexico
253 rdf:type schema:Organization
254 https://www.grid.ac/institutes/grid.416850.e schema:alternateName Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
255 schema:name Department of Neurology and Psychiatry, Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”, Mexico City, DF, Mexico
256 rdf:type schema:Organization
257 https://www.grid.ac/institutes/grid.492888.7 schema:alternateName Novartis (Mexico)
258 schema:name Department of Health Economics, Novartis Mexico, Mexico City, DF, Mexico
259 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...